Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: Individual participant meta-analysis of 154,211 adults in 31 prospective studies, Am. J. Epidemiol, vol.166, pp.867-879, 2007. ,
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease, Circulation, vol.106, pp.1938-1942, 2002. ,
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis, Arterioscler. Thromb. Vasc. Biol, vol.26, pp.2567-2573, 2006. ,
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives, Blood, vol.114, pp.4272-4278, 2009. ,
Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor, Cell, vol.84, pp.289-297, 1996. ,
The role of von Willebrand factor in thrombus formation ,
, Thromb. Res, vol.120, 2007.
Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro, Analysis, vol.105, pp.1431-1439, 2011. ,
Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids ,
, Biochimica et Biophysica Acta -Molecular and Cell Biology of Lipids, vol.1636, pp.119-128, 2004.
Structure and function of the platelet integrin ,
Waterfall Sequence for Intrinsic Blood Clotting, Science, vol.145, pp.1310-1312, 1964. ,
Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor, Thromb. Res, vol.40, pp.351-358, 1985. ,
Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow, J. Biol. Chem, vol.287, pp.5225-5234, 2012. ,
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis, Am. J. Pathol, vol.134, pp.1087-1097, 1989. ,
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation, Blood, vol.81, pp.734-744, 1993. ,
Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa, Thromb. Res, vol.46, pp.325-335, 1987. ,
Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion, Blood, vol.53, 1979. ,
The role of phospholipid and factor VIII(a) in the activation of bovine factor X, J. Biol. Chem, vol.256, pp.3433-3442, 1981. ,
Role of phospholipids and factor-Va in the prothrombinase complex, J. Biol. Chem, vol.255, pp.274-283, 1980. ,
The contact activation and kallikrein/kinin systems: Pathophysiologic and physiologic activities, Journal of Thrombosis and Haemostasis, vol.14, pp.28-39, 2016. ,
Human factor XII (Hageman Factor) autoactivation by dextran sulfate, J. Biol. Chem, vol.267, pp.19691-19697, 1992. ,
Autoactivatability of human Hageman factor (factor XII), Biochem. Biophys. Res. Commun, vol.92, pp.803-810, 1980. ,
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors, Biochemistry, vol.21, pp.567-572, 1982. ,
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen, J. Clin. Invest, vol.69, pp.844-52, 1982. ,
Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo, Thromb. Haemost, vol.92, pp.503-511, 2004. ,
Defective thrombus formation in mice lacking coagulation factor XII, J. Exp. Med, vol.202, pp.271-281, 2005. ,
Pathogenesis of serratial infection: Activation of the hageman factor-prekallikrein cascade by serratial protease, J. Biochem, vol.96, pp.739-749, 1984. ,
Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases, J. Biol. Chem, vol.264, pp.10589-10594, 1989. ,
Activation of the contact-phase system on bacterial surfaces-a clue to serious complications in infectious diseases, Nat. Med, vol.4, pp.298-302, 1998. ,
Dual role of collagen in factor XII-dependent thrombus formation, Blood, vol.114, pp.881-890, 2009. ,
Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes, Blood, vol.90, pp.3819-3843, 1997. ,
Activation of plasminogen by human plasma kallikrein ,
, Biochem. Biophys. Res. Commun, vol.35, pp.273-279, 1969.
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments, J. Clin. Invest, vol.62, pp.54-60, 1978. ,
Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells, Proc. Natl. Acad. Sci. U. S. A, vol.84, pp.1886-90, 1987. ,
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples, Blood, vol.78, pp.387-393, 1991. ,
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor, Nature, vol.338, pp.518-520, 1989. ,
The haemostatic role of tissue factor pathway inhibitor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, pp.233-242, 2008. ,
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase, Blood, vol.87, pp.1845-50, 1996. ,
Heparin and Blood Clotting, Science, vol.90, p.539, 1939. ,
Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding, J. Biol. Chem, vol.260, pp.610-615, 1985. ,
Some properties of antithrombin-III and its concentration in human plasma, Thromb. Res, vol.18, pp.259-262, 1980. ,
Hemostasis and Thrombosis, basic principles and clinical practic, 2012. ,
Crystal structure of ovalbumin as a model for the reactive centre of serpins, Nature, vol.347, pp.99-102, 1990. ,
Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin, J. Biol. Chem, vol.274, pp.4586-93, 1999. ,
Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.4808-4821, 1999. ,
Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding, Biochemistry, vol.35, pp.8495-8503, 1996. ,
Cell surface haparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties ,
, J.Biol.Chem, vol.267, pp.20435-20443, 1992.
Complete antithrombin deficiency in mice results in embryonic lethality, J. Clin. Invest, vol.106, pp.873-878, 2000. ,
The cytoprotective protein C pathway, Blood, vol.109, pp.3161-3172, 2007. ,
Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A), Thromb. Diath. Haemorrh, vol.5, pp.218-267, 1960. ,
A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization, J. Biol. Chem, vol.251, pp.355-363, 1976. ,
The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex, Proc. Natl. Acad. Sci. U. S. A, vol.93, pp.10212-10218, 1996. ,
& Angelillo-Scherrer, A. Generation and phenotypic analysis of protein S-deficient mice, Blood, vol.114, pp.2307-2314, 2009. ,
Activated protein C: From structure/function relationship to the design of recombinant proteins with targeted activities, Hematologie, vol.18, pp.96-108, 2012. ,
Un nouveau dysfibrinogène: le fibrinogene grenoble, 1983. ,
& 2-Plasmininhibitor deficiency (Miyasato disease), Lancet, vol.312, pp.1334-1336, 1978. ,
Congenital deficiency of & 2-plasmin inhibitor associated with severe hemorrhagic tendency, J. Clin. Invest, vol.63, pp.877-884, 1979. ,
A new life-long hemorrhagic disorder due to excess plasminogen activator, Blood, vol.61, pp.267-75, 1983. ,
Synthesis of human plasminogen by the liver, Science, vol.208, pp.1036-1037, 1980. ,
Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system, J. Biol. Chem, vol.265, pp.6104-6111, 1990. ,
The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen, Thromb. Res, vol.10, pp.213-222, 1977. ,
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin, EMBO J, vol.5, pp.3525-3555, 1986. ,
Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis, J. Biol. Chem, vol.268, pp.18554-18559, 1993. ,
The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies, Blood, vol.117, pp.661-668, 2011. ,
Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines, Biochemistry, vol.30, pp.7630-7638, 1991. ,
Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy, J. Mol. Biol, vol.235, pp.1117-1135, 1994. ,
Structural studies of fibrinolysis by electron microscopy, Blood, vol.92, pp.4721-4730, 1998. ,
Proteolytic fragmentation of fibrinogen. I. Comparison of the fragmentation of human and bovine fibrinogen by trypsin or plasmin, Biochemistry, vol.15, pp.5372-5381, 1976. ,
Fibrin formation, structure and properties, Subcell. Biochem, vol.82, pp.405-456, 2017. ,
Fast-acting plasmin inhibitor in human plasma, Blood, vol.51, pp.563-572, 1978. ,
Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor, Blood, vol.75, pp.671-676, 1990. ,
Regulation of fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, pp.2445-2453, 2006. ,
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombinthrombomodulin complex, J. Biol. Chem, vol.271, pp.16603-16608, 1996. ,
Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of Thrombin-Activable Fibrinolysis Inhibitor*, J. Biol. Chem, 1997. ,
Fibrinolysis, new : fibrinolytic microvesicles, Rev. Hematol, vol.114, pp.55-64, 2013. ,
, du diagnostic au traitement. in Hématologie, vol.1, pp.199-208, 1995.
Anomalies constitutionnelles de la fibrinolyse et syndromes hémorragiques, Revue Francophone des Laboratoires, vol.2012, pp.39-45, 2012. ,
Les facteurs de risque génétique de la thrombose veineuse: Où en sommes nous, Sang Thrombose Vaisseaux, vol.22, pp.421-427, 2010. ,
Genetic susceptibility to venous thrombosis, N. Engl. J. Med, vol.344, pp.1222-1231, 2001. ,
Calibrated automated thrombin generation measurement in clotting plasma, Pathophysiol. Haemost. Thromb, vol.33, pp.4-15, 2003. ,
Thrombin generation tests, Thromb. Res, vol.127, pp.21-25, 2011. ,
Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren, Klin. Wochenschr, vol.26, pp.577-583, 1948. ,
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk, Thrombosis Journal, vol.13, p.4, 2015. ,
Le Congrès Conférence d'Essentiel Place de la thromboélastographie, 2017. ,
The TEG ® 6s on shaky ground? A novel assessment of the TEG ® 6s ,
, J Extra Corpor Technol, vol.4949, pp.26-926, 2017.
Assays of different aspects of haemostasis -what do they measure?, Thrombosis Journal, vol.13, 2015. ,
Fibrin gel structure and clotting time, Thromb. Res, vol.25, pp.51-70, 1982. ,
An international study on the standardization of fibrin clot permeability measurement: Methodological considerations and implications for healthy control values, J. Thromb. Haemost, vol.10, pp.2179-2181, 2012. ,
Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure, Blood, vol.82, pp.2462-2469, 1993. ,
Sedimentation von Makromolekülen und Durchströmung von Gelen, Recl. des Trav. Chim. des Pays-Bas, vol.69, pp.45-58, 1950. ,
Analysis of fibrous network fluid permeation data using the theory of ultracentrifugation: Application to fibrin gels, Biophys. Chem, vol.81, pp.1-6, 1999. ,
Mass-length ratio of fibrin fibers from gel permeation and light scattering, Biopolymers, vol.16, pp.1-15, 1977. ,
Microscopy apparatus. United States Pat. Off, 1961. ,
Fluorescence microscopy today, Nature Methods, vol.2, 2005. ,
Smooth 2D manifold extraction from 3D image stack, Nat. Commun, vol.8, p.15554, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02425382
Atomic force microscope, Phys. Rev. Lett, vol.56, pp.930-933, 1986. ,
Surface Studies by Scanning Tunneling Microscopy, Phys. Rev. Lett, vol.49, p.57, 1982. ,
La microscopie à force atomique dans la recherche en biologie ,
Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency, Talanta, vol.180, pp.282-291, 2018. ,
Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics, Blood Coagul. Fibrinolysis, vol.23, pp.498-507, 2012. ,
Hemophilia A and B are associated with abnormal spatial dynamics of clot growth, Biochim. Biophys. Acta -Gen. Subj, vol.1572, pp.45-57, 2002. ,
Assembly of fibrin. A light scattering study, J. Biol. Chem, vol.254, pp.11272-11281, 1979. ,
The overall hemostasis potential: A laboratory tool for the investigation of global hemostasis, Seminars in Thrombosis and Hemostasis, vol.36, pp.772-779, 2010. ,
A new global assay of coagulation and fibrinolysis, Thromb. Res, vol.116, pp.345-356, 2005. ,
Clot waveform analysis: Where do we stand in 2017?, International Journal of Laboratory Hematology, vol.39, pp.561-568, 2017. ,
The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay, J. Thromb. Haemost, vol.4, pp.377-384, 2006. ,
Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca++-dependent complex of Creactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation, Blood, vol.100, pp.2522-2529, 2002. ,
Scientific and Standardization Committee. Towards standardization of clot waveform analysis and recommendations for its clinical applications, J. Thromb. Haemost, vol.11, pp.1417-1420, 2013. ,
Nanostructure of the fibrin clot, Biophys. J, vol.99, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00816904
Nanostructure des fibres de fibrine, 2011. ,
URL : https://hal.archives-ouvertes.fr/tel-00639435
Influence of the nature of fibrinogen on the structure and mechanics of fibrin clots, 2016. ,
URL : https://hal.archives-ouvertes.fr/tel-01693034
Une méthode multi-longueurs d'ondes pour la détermination de la structure du caillot en plasma, 2016. ,
Analyzing fibrin clot structure using a microplate reader, Blood Coagul. Fibrinolysis, vol.13, pp.533-539, 2002. ,
Fibrinography: A multiwavelength light-scattering assay of fibrin structure, HemaSphere, vol.3, p.166, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02406331
, New Compr. Biochem, vol.13, pp.171-241, 1986.
The Fibrinogen Molecule: Its Size, Shape, and Mode of Polymerization, J. Cell Biol, vol.5, pp.11-27, 1959. ,
The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties, Ann. Inst. Pasteur (Paris), vol.100, pp.377-389, 1961. ,
Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin, Nature, vol.389, pp.455-462, 1997. ,
Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution, Proc. Natl. Acad. Sci, vol.98, pp.11967-11972, 2001. ,
The crystal structure of modified bovine fibrinogen, Proc. Natl. Acad. Sci, vol.97, pp.85-90, 2000. ,
Crystal structure of native chicken fibrinogen at 2.7Å resolution, Biochemistry, vol.40, pp.12515-12523, 2001. ,
Fibrin polymerization sites in fibrinogen and fibrin fragments, Ann. N. Y. Acad. Sci, vol.408, pp.301-314, 1983. ,
Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers, Proc. Natl. Acad. Sci. U. S. A, vol.75, pp.3085-3089, 1978. ,
Recommendations for nomenclature on fibrinogen and fibrin, Journal of Thrombosis and Haemostasis, vol.7, pp.355-359, 2009. ,
The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots, J. Mol. Biol, vol.232, pp.285-97, 1993. ,
Electron Microscopy Of Fibrinogen, It's Plasmic Fragments And Small Polymers, Ann. N. Y. Acad. Sci, vol.408, pp.146-163, 1983. ,
Fibrinopeptides A and B release in the process of surface fibrin formation, Blood, vol.117, pp.1700-1705, 2011. ,
, Structural Basis of Interfacial Flexibility in Fibrin Oligomers. Structure, vol.24, pp.1907-1917, 2016.
Stable complex of fibrinogen and fibrin, Science, vol.152, pp.1069-1071, 1966. ,
The Fibrin Intermediate ,
, Ann. N. Y. Acad. Sci, vol.936, pp.147-66, 2001.
Crystal structure of fragment double-D from human fibrin with two different bound ligands, Biochemistry, vol.37, pp.8637-8642, 1998. ,
Functional characterization of fibrinogen Bicêtre II: A 308 AsnuLys mutation located near the fibrin D:D interaction sites, Blood Coagul. Fibrinolysis, vol.17, pp.193-201, 2006. ,
Impaired protofibril formation in fibrinogen N308K is due to altered D:D and « A:a » interactions, Biochemistry, vol.48, pp.8656-8663, 2009. ,
Twisting of fibrin fibers limits their radial growth, Proc. Natl. Acad. Sci. U. S. A, vol.84, pp.8991-8995, 1987. ,
Electron microscope investigation of the early stages of fibrin assembly. Twisted protofibrils and fibers, J. Mol. Biol, vol.216, pp.503-509, 1990. ,
Visualization and identification of the structures formed during early stages of fibrin polymerization, Blood, vol.117, pp.4609-4614, 2011. ,
Structure of the fibrin protofibril, Proc. Natl. Acad. Sci, vol.78, pp.4872-4876, 1981. ,
The Mechanism of Polymerization of Fibrinogen, Proc. Natl. Acad. Sci. U. S. A, vol.38, pp.566-575, 1952. ,
A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides, Proc. Natl. Acad. Sci, vol.97, pp.14156-14161, 2000. ,
Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions, Blood, vol.109, pp.130-138, 2007. ,
Phenomenological analysis of the clotting ¢ ¤ curve, J. Protein Chem, vol.10, pp.455-468, 1991. ,
A two-step fibrinogenfibrin transition in blood coagulation, Nature, vol.275, pp.501-505, 1978. ,
B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a, J. Thromb. Haemost, vol.5, pp.2352-2359, 2007. ,
Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides, Biophys. J, vol.50, pp.1079-1093, 1986. ,
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin), Blood, vol.69, pp.1073-81, 1987. ,
Unusual A alpha 16Arg->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings, Blood Coagul. Fibrinolysis, vol.4, pp.67-71, 1993. ,
Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism, Biochemistry, vol.39, pp.9843-9849, 2000. ,
Fibrinogens Kosai and Ogasa: BS15GlyuCys (GGTuTGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregation, J. Thromb. Haemost, vol.1, pp.275-283, 2003. ,
Carboxyl-terminal portions of the & chains of fibrinogen and fibrin ,
, J. Biol. Chem, vol.268, pp.13577-13585, 1993.
, , 2010.
Transamidase activity of the enzyme responsible for insoluble fibrin formation, Arch. Biochem. Biophys, vol.113, pp.435-438, 1966. ,
Transglutaminase activity of the fibrin crosslinking enzyme, Biochem. Biophys. Res. Commun, vol.24, 1966. ,
Studies on fibrin crosslinking. Nature of the acceptor groups in transpeptidation, Biochem. Biophys. Res. Commun, vol.23, pp.188-193, 1966. ,
Quantitative determination of amino-terminal amino acids in crosslinked and non-crosslinked fibrin, Biochem. Biophys. Res. Commun, vol.26, pp.327-333, 1967. ,
Cross-linking sites in human and bovine fibrin ,
, Biochemistry, vol.10, pp.4486-4491, 1971.
Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxyterminal cyanogen bromide gamma-chain fragments, Biochem istry, vol.26, pp.4640-4646, 1987. ,
Cross-linked -chains in fibrin fibrils bridge transversely between strands: No, J. Thromb. Haemost, vol.2, pp.394-399, 2004. ,
Cross-linked -chains in fibrin fibrils bridge transversely between strands: Yes, J. Thromb. Haemost, vol.2, pp.388-393, 2004. ,
Covalent structure of single-stranded fibrin oligomers cross-linked by FXIIIa, Biochem. Biophys. Res. Commun, vol.461, pp.408-412, 2015. ,
Factor XIIIacatalyzed cross-linking of recombinant & C fragments of human fibrinogen ,
, Biochemistry, vol.35, pp.5810-5816, 1996.
Functional analysis of fibrin -chain cross-linking by activated factor XIII: Determination of a cross-linking pattern that maximizes clot stiffness, Blood, vol.110, pp.902-907, 2007. ,
Cross-linking of & 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor, J. Biol. Chem, vol.257, pp.14767-14772, 1982. ,
Human procarboxypeptidase U, or thrombinactivable fibrinolysis inhibitor, is a substrate for transglutaminases: Evidence for transglutaminase-catalyzed cross-linking to fibrin, J. Biol. Chem, vol.273, pp.27220-27224, 1998. ,
Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin, Thromb. Haemost, vol.81, pp.96-103, 1999. ,
Biomechanics of haemostasis and thrombosis in health and disease: from the macro-to molecular scale, J. Cell. Mol. Med, vol.17, pp.579-596, 2013. ,
Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis, Thromb. Haemost, vol.104, pp.1281-1285, 2010. ,
Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism, Am. J. Physiol. Cell. Mol. Physiol, vol.306, pp.397-404, 2014. ,
, A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism. Br
, J. Haematol, vol.168, pp.571-575, 2015.
Fractal dimension (df ) as a new structural biomarker of clot microstructure in different stages of lung cancer, Thromb. Haemost, vol.114, pp.1251-1259, 2015. ,
Fibrin fibers have extraordinary extensibility and elasticity, Science, vol.313, p.634, 2006. ,
Multiscale Mechanics of Fibrin Polymer: Gel Stretching with Protein Unfolding and Loss of Water, Science, vol.325, pp.741-744, 2009. ,
Structural Hierarchy Governs Fibrin Gel Mechanics, Biophys. J, vol.98, pp.2281-2289, 2010. ,
The Biochemical and Physical Process of Fibrinolysis and Effects of Clot Structure and Stability on the Lysis Rate ,
, Cardiovasc. Hematol. Agents Med. Chem, vol.6, pp.161-180, 2008.
Structure of fibrin: Impact on clot stability, Journal of Thrombosis and Haemostasis, vol.5, pp.116-124, 2007. ,
The effect of fibrin structure on fibrinolysis, J. Biol. Chem, vol.267, pp.24259-24263, 1992. ,
Basic mechanisms and regulation of fibrinolysis, J. Thromb. Haemost, vol.13, pp.98-105, 2015. ,
A Structural and Dynamic Investigation of the Facilitating Effect of Glycoprotein IIb/IIIa Inhibitors in Dissolving Platelet-Rich Clots, Circ. Res, vol.90, pp.428-434, 2002. ,
Hindered dissolution of fibrin formed under mechanical stress, J. Thromb. Haemost, vol.9, pp.979-986, 2011. ,
Demonstration of a large molecular weight variant of the chain of normal human plasma fibrinogen ,
, Biol. Chem, vol.255, pp.5599-5604, 1980.
Gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing, Biochemistry, vol.23, pp.4232-4238, 1984. ,
The presence of á ,
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure, Blood, vol.102, pp.535-540, 2003. ,
Thrombin and fibrinogen á impact clot structure by marked effects on intrafibrillar structure and protofibril packing, Blood, vol.127, pp.487-495, 2016. ,
Resistance of gammaA/gamma' fibrin clots to fibrinolysis, J. Biol. Chem, vol.272, pp.14251-14257, 1997. ,
Association of gammaA/gamma' fibrinogen levels and coronary artery disease, Thromb. Haemost, vol.88, pp.26-31, 2002. ,
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen ' levels, Blood, vol.106, pp.4176-4183, 2005. ,
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors, J. Thromb. Haemost, vol.5, pp.766-773, 2007. ,
Elevated fibrinogen ' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome, Blood, vol.114, pp.4603-4604, 2009. ,
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms, Blood, vol.100, pp.743-54, 2002. ,
Genetic and Environmental Determinants of Fibrin Structure and Function, Arterioscler. Thromb. Vasc. Biol, vol.24, pp.1558-1566, 2004. ,
Fibrinogen Non-Inherited Heterogeneity and Its Relationship to Function in Health and Disease, Ann. N. Y. Acad. Sci, vol.936, pp.580-593, 2001. ,
Fibrin clot structure in patients with congenital dysfibrinogenaemia, Thromb. Res, vol.137, pp.189-195, 2016. ,
The dysfibrinogenaemias, Br. J. Haematol, vol.114, pp.249-257, 2001. ,
Hereditary Disorders of Fibrinogen, Ann. N. Y. Acad. Sci, vol.936, pp.65-88, 2001. ,
Congenital fibrinogen disorders, Semin. Thromb. Hemost, vol.35, pp.356-366, 2009. ,
The molecular basis of quantitative fibrinogen disorders, Journal of Thrombosis and Haemostasis, vol.4, pp.2115-2129, 2006. ,
Congenital Fibrinogen Disorders: An Update, Semin. Thromb. Hemost, vol.39, pp.585-595, 2013. ,
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency, Thromb. Haemost, vol.113, pp.567-576, 2015. ,
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management, J. Thromb. Haemost, vol.13, pp.909-919, 2015. ,
Effect of temperature, ph and ionic strength and composition on fibrin network structure and its development, Thromb. Res, vol.42, pp.809-816, 1986. ,
Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels, Biochem. J, vol.239, pp.513-519, 1986. ,
Size and density of fibrin fibers from turbidity, Macromolecules, vol.11, pp.46-50, 1978. ,
Native fibrin gel networks observed by 3D microscopy, permeation and turbidity, Biochim. Biophys. Acta -Protein Struct. Mol. Enzymol, vol.997, pp.96-110, 1989. ,
Thrombin generation and fibrin clot structure, Blood Rev, vol.21, pp.131-142, 2007. ,
, Advances in Protein Chemistry, vol.70, pp.247-299, 2005.
Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes, Thromb. Haemost, vol.102, pp.1169-75, 2009. ,
,
Platelet control of fibrin distribution and microelasticity in thrombus formation under flow, Arterioscler. Thromb. Vasc. Biol, vol.36, pp.692-699, 2016. ,
Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow, Biophys. J, vol.98, pp.1344-1352, 2010. ,
Flow rate and fibrin fiber alignment, J. Thromb. Haemost, vol.8, pp.2826-2828, 2010. ,
Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults, Thromb. Res, vol.127, pp.317-323, 2011. ,
Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM), Int. J. Lab ,
URL : https://hal.archives-ouvertes.fr/hal-01958965
, , vol.40, pp.84-93, 2018.
Fast twodimensional bubble analysis of biopolymer filamentous networks pore size from confocal microscopy thin data stacks, Biophys. J, vol.104, pp.1160-1169, 2013. ,
A simplified implementation of the bubble analysis of biopolymer network pores, Biophys. J, vol.104, pp.2774-2779, 2013. ,
Advanced thrombinoscopy, 2007. ,
What is all that thrombin for?, Journal of Thrombosis and Haemostasis, vol.1, pp.1504-1514, 2003. ,
The effect of fibrin(ogen) on thrombin generation and decay, Thromb. Haemost, vol.112, pp.486-494, 2014. ,
The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by & 2-macroglobulin-thrombin ,
, Thromb. Haemost, vol.8, pp.1281-1289, 2010.
Antithrombinindependent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulinprotein C system, Thromb. Haemost, vol.106, pp.1076-1083, 2011. ,
A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation ,
, Thromb. Res, vol.141, pp.77-83, 2016.
Estimating the 3D pore size distribution of biopolymer networks from directionally biased data, Biophys. J, vol.105, pp.1967-1975, 2013. ,
A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III, J. Biol. Chem, vol.266, pp.13003-13013, 1991. ,
Calibrating Thrombin Generation in Different Samples: Less Effort with a Less Efficient Substrate. Open Atheroscler, Thromb. J, vol.2, pp.6-11, 2009. ,